Aurinia Pharmaceuticals (AUPH) Treasury Shares (2020 - 2026)

Aurinia Pharmaceuticals has reported Treasury Shares for 7 years, with the latest figure at $2.5 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares fell 56.9% year-over-year to $2.5 million; the trailing twelve-month figure through Mar 2026 stood at $2.5 million (down 56.9% YoY), and the FY2025 full-year result was $4.0 million, down 49.65% from the prior year.
• Treasury Shares for Q1 2026 stood at $2.5 million, down from $4.0 million in the prior quarter.
• The five-year high for Treasury Shares was $12.2 million in Q3 2025, with the low at $2.0 million in Q1 2022.
• Historically, Treasury Shares has averaged $5.4 million across 5 years, with a median of $4.0 million in 2025.
• The largest YoY upside for Treasury Shares was 470.61% in 2022 against a maximum downside of 86.78% in 2022.
• Aurinia Pharmaceuticals' Treasury Shares stood at $2.0 million in 2022, then surged by 294.29% to $7.8 million in 2023, then gained by 2.29% to $8.0 million in 2024, then sank by 49.65% to $4.0 million in 2025, then sank by 37.83% to $2.5 million in 2026.
• The last three Treasury Shares figures came in at $2.5 million (Q1 2026), $4.0 million (Q4 2025), and $12.2 million (Q3 2025), per Business Quant data.